T. Ranzi

Epidemiological aspects of inflammatory bowel disease in a north Italian population: a 4-year prospective study.

P. Bianchi, A. Zambelli, P. Politi, 1996, European journal of gastroenterology & hepatology.

Controlled trial of oral 5‐aminosalicylic acid for the prevention of early relapse in Crohn's disease

A. Prada, R. Franchis, M. Vecchi, 1997, Alimentary pharmacology & therapeutics.

Mesalazine (5-aminosalicylic acid) suppositories in the treatment of ulcerative proctitis or distal proctosigmoiditis. A randomized controlled trial.

G. Porro, M. Campieri, L. Barbara, 1990, Scandinavian journal of gastroenterology.

Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group.

V. Annese, G. Sturniolo, F. Rossini, 1999, Italian journal of gastroenterology and hepatology.

Final report on a placebo-controlled, double-blind, randomized, multicentre trial of cyclosporin treatment in active chronic Crohn's disease.

O. B. Schaffalitzky de Muckadell, K. Lauritsen, V. Binder, 1991, Scandinavian journal of gastroenterology.